We can start with laws that limit the power of pharmacy-benefit managers ...

Humira (adalimumab) is a long-term maintenance medication used to manage chronic conditions like Crohn’s disease and rheumatoid arthritis. For many people, this drug is not a short-term fix but a ...

Boehringer Ingelheim has decided to reduce its U.S. salesforce as its biosimilars targeting AbbVie's (NYSE:ABBV) blockbuster arthritis therapy, Humira, has lagged expectations, the German drugmaker ...

AbbVie is a leading pharmaceutical company with a diverse portfolio of products and strong revenue growth. The company has a solid track record of increasing dividends and offers an attractive current ...

The biosimilar price is about 85% lower than that of branded Humira. More than 100,000 Accredo patients use either Humira or one of its biosimilars. 9 Out of the Last 10 Summers this "Power Pattern" ...

WASHINGTON, Dec 23 (Reuters) - An advertisement for Abbott Laboratories' Humira minimizes the arthritis drug's risks while suggesting it can treat a wider range of patients than it is approved to ...